DCIS in BRCA1 and BRCA2 mutation carriers: prevalence, phenotype, and expression of oncodrivers C-MET and HER3

BACKGROUND: Studies report conflicting evidence regarding the existence of a DCIS-associated premalignant pathway in BRCA mutation carriers. We aimed to examine the prevalence, phenotype, and expression of oncodrivers in pure DCIS (pDCIS) and invasive breast cancer with concurrent DCIS (IBC + DCIS)...

Descripción completa

Detalles Bibliográficos
Autores principales: Yang, Rachel L., Mick, Rosemarie, Lee, Kathreen, Graves, Holly L., Nathanson, Katherine L., Domchek, Susan M., Kelz, Rachel R., Zhang, Paul J., Czerniecki, Brian J.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2015
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4619378/
https://www.ncbi.nlm.nih.gov/pubmed/26496879
http://dx.doi.org/10.1186/s12967-015-0698-3

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4619378/
https://www.ncbi.nlm.nih.gov/pubmed/26496879
http://dx.doi.org/10.1186/s12967-015-0698-3

Ejemplares similares